Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2025 12:02 ET | Source: Bavarian Nordic A/S

Correction: Beslutninger på den ordinære generalforsamling 2025 i Bavarian Nordic A/S

KØBENHAVN, Danmark, 9. april 2025 – Bavarian Nordic A/S (OMX: BAVA) har i dag afholdt ordinær generalforsamling med følgende resultater: Årsrapporten for 2024 blev godkendt. Bestyrelsens forslag om,...
April 09, 2025 12:02 ET | Source: Bavarian Nordic A/S

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2024 was adopted. The Board of Directors’...
April 09, 2025 11:38 ET | Source: Bavarian Nordic A/S

Beslutninger på den ordinære generalforsamling 2025 i Bavarian Nordic A/S

KØBENHAVN, Danmark, 9. april 2025 – Bavarian Nordic A/S (OMX: BAVA) har i dag afholdt ordinær generalforsamling med følgende resultater: Årsrapporten for 2024 blev godkendt. Bestyrelsens forslag om,...
April 09, 2025 11:38 ET | Source: Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2024 was adopted. The Board of Directors’...
March 31, 2025 16:38 ET | Source: Bavarian Nordic A/S

Bavarian Nordic modtager FDA-godkendelse af frysetørret koppe- og mpoxvaccine

KØBENHAVN, Danmark, 31. marts 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at de amerikanske lægemiddelmyndigheder, U.S. Food and Drug Administration (FDA) har godkendt den frysetørrede...
March 31, 2025 16:38 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS® (Smallpox...
March 12, 2025 07:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Indkaldelse til ordinær generalforsamling

KØBENHAVN, Danmark, 12. marts 2025 – I overensstemmelse med vedtægternes §§ 10-14 indkaldes herved til ordinær generalforsamling i Bavarian Nordic A/S: Onsdag den 9. april 2025 kl. 16.00 hos Comwell...
March 12, 2025 07:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S – Notice Convening Annual General Meeting

COPENHAGEN, Denmark, March 12, 2025 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the Annual General Meeting to be held on...
March 07, 2025 01:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordics ansøgning om markedsføringstilladelse for chikungunyavaccinen for personer i alderen 12 år og ældre er blevet accepteret af de britiske lægemiddelmyndigheder

KØBENHAVN, Danmark, 7. marts 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at de britiske lægemiddelmyndigheder, UK Medicines and Healthcare products Regulatory Agency (MHRA), har...
March 07, 2025 01:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older

COPENHAGEN, Denmark, March 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has validated the marketing authorization...